Current Cancer Therapy Reviews

Editor-in-Chief:

Kurt S. Zaenker
Institute of Immunology and Experimental Oncology
Witten/Herdecke University
Stockumerstraße 10, 58448 Witten
Germany

Back

Become EABM
Become Reviewer

Familial Central Nervous System Tumor Syndromes

Volume:2   Issue: 4
Pp: 281-291
Andreas F. Hottinger, Yasmin Khakoo and Lauren E. Abrey
DOI: 10.2174/157339406778699222

The ABCs of Targeting Raf: Novel Approaches to Cancer Therapy

Volume:2   Issue: 4
Pp: 305-314
Rebecca Kinkade, Piyali Dasgupta and Srikumar Chellappan
DOI: 10.2174/157339406778699204

Adjuvant Therapy in Elderly Patients with Early Breast Cancer

Volume:2   Issue: 4
Pp: 315-325
Silvia Dellapasqua, Alessandra Balduzzi, Aron Goldhirsch and Marco Colleoni
DOI: 10.2174/157339406778699169

The Role of FDA in the Regulation of Anti-Cancer Drugs

Volume:2   Issue: 4
Pp: 327-329
Ramzi N. Dagher and Richard Pazdur
DOI: 10.2174/157339406778699196

Estrogen in Prostate Cancer - Friend or Foe?

Volume:2   Issue: 4
Pp: 341-349
Eva Corey
DOI: 10.2174/157339406778699231

Cancer Rehabilitation: Recommendations for Integrating Exercise Programming in the Clinical Practice Setting

Volume:2   Issue: 4
Pp: 351-360
Margaret L. McNeely, Carolyn J. Peddle, Matthew Parliament and Kerry S. Courneya
DOI: 10.2174/157339406778699187